* 23andMe Holding Co. ME.OQ reported a quarterly adjusted
loss
of 11 cents per share for the quarter ended in January, higher
than the same quarter last year, when the company reported EPS
of -14 cents. The mean expectation of two analysts for the
quarter was for a loss of 15 cents per share.
* Revenue fell 30.7% to $64.03 million from a year ago;
analysts
expected $56.87 million.
* 23andMe Holding Co. shares had fallen by 4.2% this
quarter and
lost 44.2% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 1.6%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the healthcare
facilities & services peer group is "hold."
Wall Street's median 12-month price target for 23andMe Holding
Co. is $1.24
This summary was machine generated from LSEG data May 24 at
08:51 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.15 -0.11 Beat
Dec. 31 2023 -0.14 -0.16 Missed
Sep. 30 2023 -0.14 -0.16 Missed
Jun. 30 2023 -0.15 -0.23 Missed